ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALLR Allarity Therapeutics Inc

0.699051
0.01895 (2.79%)
Last Updated: 16:03:28
Delayed by 15 minutes
Share Name Share Symbol Market Type
Allarity Therapeutics Inc NASDAQ:ALLR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01895 2.79% 0.699051 0.698 0.705 0.70 0.6622 0.6742 1,297,892 16:03:28

Additional Proxy Soliciting Materials (definitive) (defa14a)

06/12/2022 10:20pm

Edgar (US Regulatory)


 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

SCHEDULE 14A

 

 

 

PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Filed by the Registrant

 

Filed by a Party other than the Registrant

 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under §240.14a-12

 

ALLARITY THERAPEUTICS, INC.

 

(Name of Registrant as Specified In Its Charter)

 

 

 

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

No fee required.

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 Year Allarity Therapeutics Chart

1 Year Allarity Therapeutics Chart

1 Month Allarity Therapeutics Chart

1 Month Allarity Therapeutics Chart